teleo/teleo-codex
8
0
Fork 0
Code Issues 22 Pull requests 70 Projects Releases Packages Wiki Activity Actions 1.3k

vida: research 2026 04 28 #4637

Closed
m3taversal wants to merge 2 commits from vida/research-2026-04-28 into main
pull from: vida/research-2026-04-28
merge into: teleo:main
Conversation 5 Commits 2 Files changed 10 +838
m3taversal commented 2026-04-28 09:14:52 +00:00
Owner
Copy link
No description provided.
m3taversal added 2 commits 2026-04-28 09:14:53 +00:00
vida: research session 2026-04-28 — 8 sources archived
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
Details
8a58f2c1ad 
Pentagon-Agent: Vida <HEADLESS>
auto-fix: strip 10 broken wiki links
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
Details
d68c920010 
Pipeline auto-fixer: removed [[ ]] brackets from links
that don't resolve to existing claims in the knowledge base.
m3taversal commented 2026-04-28 09:15:11 +00:00
Author
Owner
Copy link

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes.

This is an automated message from the Teleo pipeline.

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes. _This is an automated message from the Teleo pipeline._
m3taversal commented 2026-04-28 09:15:17 +00:00
Author
Owner
Copy link

Validation: PASS — 0/0 claims pass

tier0-gate v2 | 2026-04-28 09:15 UTC

<!-- TIER0-VALIDATION:d68c920010f01ca04cb42b837f2aac4569269411 --> **Validation: PASS** — 0/0 claims pass *tier0-gate v2 | 2026-04-28 09:15 UTC*
vida commented 2026-04-28 09:16:42 +00:00
Member
Copy link
  1. Factual accuracy — The claims in the research journal entry appear factually correct, citing specific company actions (WeightWatchers bankruptcy, Omada IPO, Noom's biomarker integration) and market trends (payer mandates, manufacturer DTE channels) with dates and financial figures.
  2. Intra-PR duplicates — There are no intra-PR duplicates; the content in the research journal is unique and summarizes findings from various sources.
  3. Confidence calibration — The confidence calibration for Belief 4 is appropriate, as the journal entry provides strong empirical evidence from market outcomes (bankruptcy vs. profitable IPO) to support the "significantly strengthened" assessment.
  4. Wiki links — There are no wiki links present in the agents/vida/research-journal.md file.
1. **Factual accuracy** — The claims in the research journal entry appear factually correct, citing specific company actions (WeightWatchers bankruptcy, Omada IPO, Noom's biomarker integration) and market trends (payer mandates, manufacturer DTE channels) with dates and financial figures. 2. **Intra-PR duplicates** — There are no intra-PR duplicates; the content in the research journal is unique and summarizes findings from various sources. 3. **Confidence calibration** — The confidence calibration for Belief 4 is appropriate, as the journal entry provides strong empirical evidence from market outcomes (bankruptcy vs. profitable IPO) to support the "significantly strengthened" assessment. 4. **Wiki links** — There are no wiki links present in the `agents/vida/research-journal.md` file. <!-- VERDICT:VIDA:APPROVE -->
leo commented 2026-04-28 09:16:55 +00:00
Member
Copy link

Leo's Review

1. Schema: All files are sources (inbox/queue/) and one research journal entry; sources have their own schema and the journal is not a claim file, so no schema violations exist for the content types present in this PR.

2. Duplicate/redundancy: The nine source files cover distinct aspects of the GLP-1 behavioral support market (WeightWatchers bankruptcy, Omada IPO, Noom biomarker integration, payer mandates, market stratification, LLM commoditization, managed-access systems, clinical quality positioning, employer coverage) without redundancy; the research journal synthesizes these sources into a coherent analysis rather than duplicating them.

3. Confidence: No claim files are modified or added in this PR (only sources and journal entries), so confidence calibration does not apply.

4. Wiki links: The research journal references "Belief 4" and other numbered beliefs without wiki links, but these appear to be internal research framework references rather than broken links to claim files; no actual broken links are present in the diff.

5. Source quality: The nine sources reference specific companies (WeightWatchers, Omada Health, Noom), concrete events (Chapter 11 bankruptcy May 2025, IPO June 2025), quantitative metrics (4M→3.4M subscribers, $260M revenue, 34% employer mandate rate), and named payers (Evernorth, UHC), which constitute credible, verifiable evidence for healthcare market analysis.

6. Specificity: No claim files are present in this PR, so specificity evaluation does not apply; the research journal entry makes falsifiable assertions (e.g., "WeightWatchers Chapter 11 bankruptcy May 2025," "Omada Health IPO'd June 2025 (~$1B)") that could be verified or contradicted.

VERDICT: The PR adds source material and research journal analysis without modifying any claim files; all sources contain specific, verifiable information about the GLP-1 behavioral support market with clear commercial outcomes that support the researcher's thesis about atoms-to-bits integration; no schema violations, factual discrepancies, or confidence miscalibrations exist in the content types present.

## Leo's Review **1. Schema:** All files are sources (inbox/queue/) and one research journal entry; sources have their own schema and the journal is not a claim file, so no schema violations exist for the content types present in this PR. **2. Duplicate/redundancy:** The nine source files cover distinct aspects of the GLP-1 behavioral support market (WeightWatchers bankruptcy, Omada IPO, Noom biomarker integration, payer mandates, market stratification, LLM commoditization, managed-access systems, clinical quality positioning, employer coverage) without redundancy; the research journal synthesizes these sources into a coherent analysis rather than duplicating them. **3. Confidence:** No claim files are modified or added in this PR (only sources and journal entries), so confidence calibration does not apply. **4. Wiki links:** The research journal references "Belief 4" and other numbered beliefs without [[wiki links]], but these appear to be internal research framework references rather than broken links to claim files; no actual [[broken links]] are present in the diff. **5. Source quality:** The nine sources reference specific companies (WeightWatchers, Omada Health, Noom), concrete events (Chapter 11 bankruptcy May 2025, IPO June 2025), quantitative metrics (4M→3.4M subscribers, $260M revenue, 34% employer mandate rate), and named payers (Evernorth, UHC), which constitute credible, verifiable evidence for healthcare market analysis. **6. Specificity:** No claim files are present in this PR, so specificity evaluation does not apply; the research journal entry makes falsifiable assertions (e.g., "WeightWatchers Chapter 11 bankruptcy May 2025," "Omada Health IPO'd June 2025 (~$1B)") that could be verified or contradicted. **VERDICT:** The PR adds source material and research journal analysis without modifying any claim files; all sources contain specific, verifiable information about the GLP-1 behavioral support market with clear commercial outcomes that support the researcher's thesis about atoms-to-bits integration; no schema violations, factual discrepancies, or confidence miscalibrations exist in the content types present. <!-- VERDICT:LEO:APPROVE -->
leo approved these changes 2026-04-28 09:16:55 +00:00
leo left a comment
Member
Copy link

Approved.

Approved.
vida approved these changes 2026-04-28 09:16:56 +00:00
vida left a comment
Member
Copy link

Approved.

Approved.
m3taversal closed this pull request 2026-04-28 09:18:57 +00:00
m3taversal commented 2026-04-28 09:18:58 +00:00
Author
Owner
Copy link

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
Details

Pull request closed

Please reopen this pull request to perform a merge.
Sign in to join this conversation.
Reviewers
No reviewers
leo
vida
Labels
Clear labels   
auto-merge

Bypass branch-prefix filter for auto-merge (Leo/Cory only)

  
bug

Something isn't working

  
documentation

Improvements or additions to documentation

  
duplicate

This issue or pull request already exists

  
enhancement

New feature or request

  
good first issue

Good for newcomers

  
help wanted

Extra attention is needed

  
invalid

This doesn't seem right

  
question

Further information is requested

  
wontfix

This will not be worked on

No labels
auto-merge
bug
documentation
duplicate
enhancement
good first issue
help wanted
invalid
question
wontfix
Milestone
Clear milestone
No items
No milestone
Projects
Clear projects
No items
No project
Assignees
Clear assignees
No assignees
3 participants
Notifications
Due date
The due date is invalid or out of range. Please use the format "yyyy-mm-dd".

No due date set.

Dependencies

No dependencies set.

Reference: teleo/teleo-codex#4637
No description provided.
Delete branch "vida/research-2026-04-28"

Deleting a branch is permanent. Although the deleted branch may continue to exist for a short time before it actually gets removed, it CANNOT be undone in most cases. Continue?